Literature DB >> 16241103

Genetic characterization of commonly used glioma cell lines in the rat animal model system.

Zita A Sibenaller1, Arnold B Etame, Mushtaq M Ali, Manali Barua, Terry A Braun, Thomas L Casavant, Timothy C Ryken.   

Abstract

OBJECT: Animal models have been used extensively to discern the molecular biology of diseases and to gain insight into treatments. Nevertheless, discrepancies in the effects of treatments and procedures have been encountered during the transition from these animal models to application of the information to clinical trials in humans. To assess the genetic similarities between human gliomas and four cell lines used routinely in animal models, the authors used microarray technology to characterize the similarities and differences in gene expression.
METHODS: To define the changes in gene expression, normal rat astrocytes were compared with four rat glioma cell lines (C6, 9L, F98, and RG2). The data were analyzed using two different methods: fold-change analysis and statistical analysis with t statistics. The gene products that were highlighted after intersecting the lists generated by the two methods of analysis were scrutinized against changes in gene expression reported in the literature. Tumorigenesis involves three major steps: the accumulation of genetic alterations, uncontrolled growth, and selected survival of transformed cells. The discussion of the results focuses attention on genes whose primary function is in pathways involved in glioma proliferation, infiltration, and neovascularization. A comparative microarray analysis of differentially expressed genes for four of the commonly used rat tumor cell lines is presented here.
CONCLUSIONS: Due to the variances between the cell lines and results from analyses in humans, caution must be observed in interpreting as well as in the translation of information learned from animal models to its application in human trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16241103     DOI: 10.3171/foc.2005.19.4.2

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  32 in total

1.  In vivo characterization of several rodent glioma models by 1H MRS.

Authors:  Sabrina Doblas; Ting He; Debra Saunders; Jessica Hoyle; Nataliya Smith; Quentin Pye; Megan Lerner; Randy L Jensen; Rheal A Towner
Journal:  NMR Biomed       Date:  2011-09-23       Impact factor: 4.044

Review 2.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

3.  Ketamine suppresses the proliferation of rat C6 glioma cells.

Authors:  Hidetomo Niwa; Ken-Ichi Furukawa; Kazuhiko Seya; Kazuyoshi Hirota
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

4.  Cocaine induces alterations in mitochondrial membrane potential and dual cell cycle arrest in rat c6 astroglioma cells.

Authors:  Ramesh B Badisa; Selina F Darling-Reed; Carl B Goodman
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

5.  Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.

Authors:  Sabrina Doblas; Ting He; Debbie Saunders; Jamie Pearson; Jessica Hoyle; Nataliya Smith; Megan Lerner; Rheal A Towner
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

6.  Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.

Authors:  Audrey Bouchet; Marie Bidart; Imen Miladi; Céline Le Clec'h; Raphaël Serduc; Charles Coutton; Pierrick Regnard; Enam Khalil; Sandrine Dufort; Benjamin Lemasson; Jean Laissue; Laurent Pelletier; Géraldine Le Duc
Journal:  Tumour Biol       Date:  2014-03-16

Review 7.  C6 cell line: the gold standard in glioma research.

Authors:  D Giakoumettis; A Kritis; N Foroglou
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

8.  Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors.

Authors:  Rajendar K Mittapalli; Chris E Adkins; Kaci A Bohn; Afroz S Mohammad; Julie A Lockman; Paul R Lockman
Journal:  Cancer Res       Date:  2016-11-04       Impact factor: 12.701

Review 9.  Molecular targeting of glioblastoma: Drug discovery and therapies.

Authors:  Ren-Yuan Bai; Verena Staedtke; Gregory J Riggins
Journal:  Trends Mol Med       Date:  2011-03-14       Impact factor: 11.951

10.  ELTD1, a potential new biomarker for gliomas.

Authors:  Rheal A Towner; Randy L Jensen; Howard Colman; Brian Vaillant; Nataliya Smith; Rebba Casteel; Debra Saunders; David L Gillespie; Robert Silasi-Mansat; Florea Lupu; Cory B Giles; Jonathan D Wren
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.